TAI JI GROUP FU LING PHARMACEUTICAL FACTORY – Trademark Portfolio

Entity Type: 99

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TAIJI. The owner is based in Chongqing.

No.68, Jian She Road

Fu Ling District, 408000

Chongqing , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TAIJI
TAIJI
Registered 2001

Trademark Classifications

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does TAI JI GROUP FU LING PHARMACEUTICAL FACTORY have?

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does TAI JI GROUP FU LING PHARMACEUTICAL FACTORY file in?

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are TAI JI GROUP FU LING PHARMACEUTICAL FACTORY's most well-known trademarks?

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY's registered trademark portfolio includes well-known marks such as TAIJI. These are among 1 currently registered trademark in the portfolio.

What is TAI JI GROUP FU LING PHARMACEUTICAL FACTORY's trademark registration success rate?

TAI JI GROUP FU LING PHARMACEUTICAL FACTORY has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.